Page last updated: 2024-08-24

ibutilide and Cardiac Failure

ibutilide has been researched along with Cardiac Failure in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Chen, K; Han, Y; Huang, S; Jin, Q; Lin, C; Luo, Q; Shen, W; Wei, Y; Wu, L; Zhang, N1
Aldemerdash, A; Fisch, MD; Hsu, CC; Jaynes, HA; Kovacs, RJ; Muensterman, ET; Overholser, BR; Rao, VU; Rodgers, JE; Sowinski, KM; Tisdale, JE; Wang, N1
Amankwa, K; Borzak, S; Coram, R; Flockhart, DA; Kingery, JR; Kovacs, RJ; Overholser, BR; Sowinski, KM; Tisdale, JE; Wroblewski, HA; Zipes, DP2
Angkeow, P; Berger, RD; Calkins, H; Cheng, A; Dalal, D; Fetics, BJ; Spragg, DD; Tomaselli, GF1
Amlie, JP; Harg, P; Madsen, S1

Trials

2 trial(s) available for ibutilide and Cardiac Failure

ArticleYear
Pharmacokinetics of ibutilide in patients with heart failure due to left ventricular systolic dysfunction.
    Pharmacotherapy, 2008, Volume: 28, Issue:12

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Area Under Curve; Arrhythmias, Cardiac; Catheters, Indwelling; Electrocardiography; Half-Life; Heart Failure; Heart Rate; Humans; Infusions, Intravenous; Long QT Syndrome; Male; Middle Aged; Monte Carlo Method; Prospective Studies; Remission, Spontaneous; Severity of Illness Index; Sulfonamides; Tachycardia; Time Factors; Ventricular Dysfunction, Left

2008
Enhanced sensitivity to drug-induced QT interval lengthening in patients with heart failure due to left ventricular systolic dysfunction.
    Journal of clinical pharmacology, 2012, Volume: 52, Issue:9

    Topics: Adult; Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Female; Heart Failure; Humans; Long QT Syndrome; Male; Middle Aged; Sulfonamides; Ventricular Dysfunction, Left

2012

Other Studies

4 other study(ies) available for ibutilide and Cardiac Failure

ArticleYear
Ibutilide Reduces Ventricular Defibrillation Threshold and Organizes Ventricular Fibrillation Activation in Canine Heart Failure Model.
    Cardiovascular drugs and therapy, 2020, Volume: 34, Issue:3

    Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Arterial Pressure; Disease Models, Animal; Dogs; Heart Failure; Heart Rate; Refractory Period, Electrophysiological; Sulfonamides; Time Factors; Ventricular Fibrillation

2020
Enhanced Response to Drug-Induced QT Interval Lengthening in Patients with Heart Failure with Preserved Ejection Fraction.
    Journal of cardiac failure, 2020, Volume: 26, Issue:9

    Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Failure; Humans; Male; Stroke Volume; Sulfonamides; Ventricular Function, Left

2020
Ibutilide-induced changes in the temporal lability of ventricular repolarization in patients with and without structural heart disease.
    Journal of cardiovascular electrophysiology, 2009, Volume: 20, Issue:8

    Topics: Adult; Aged; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Failure; Heart Rate; Humans; Male; Middle Aged; Sulfonamides; Tachycardia, Supraventricular; Time Factors

2009
[Severe ibutilide-induced arrhythmia in patients with heart failure].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2001, Oct-10, Volume: 121, Issue:24

    Topics: Aged; Anti-Arrhythmia Agents; Contraindications; Drug Therapy, Combination; Fatal Outcome; Heart Failure; Humans; Male; Middle Aged; Sulfonamides; Torsades de Pointes

2001